Impaired glucose tolerance and impaired fasting glucose share similar underlying pathophysiologies

Tohoku Journal of Experimental Medicine

Volumn 212, Issue 4, 2007, Pages 349-357

  Lin, Jiunn Diann ^a   Wan, Hsiang Lin ^a   Li, Jer Chuan ^a   Wu, Chung Ze ^b   Kuo, Shi Wen ^a   Hsieh, Chang Hsun ^b   Lian, Wei Chen ^a   Lee, Chien Hsing ^b   Kao, Mei Teng ^c   Pei, Dee ^a,d,e  

^a TZU CHI UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c Tzu Ai General Hospital   (Taiwan)

^d CARDINAL TIEN HOSPITAL   (Taiwan)

^e NONE   (Taiwan)

Author keywords

Factor analysis; Impaired fasting glucose; Impaired glucose tolerance; Insulin resistance; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FACTORIAL ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; DIET RESTRICTION; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; STATISTICS;

BLOOD GLUCOSE; FASTING; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MIDDLE AGED; PREDIABETIC STATE; RISK FACTORS; STATISTICS AS TOPIC;

EID: 38449086686     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.212.349     Document Type: Article

References (39)

1. American Diabetes Association: Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20, 1183-1197.
2. Balkau, B., Sapinho, D., Petrella, A., Mhamdi L., Cailleau, M., Arondel, D. & Charles, M.A. (2006) Prescreening tools for diabetes and obesity-associated-dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study. Eur. J. Clin. Nutr., 60, 295-304.
3. Bergman, R.N., Ider, Y.Z., Bowden, C.R. & Cobelli, C. (1979) Quantitative estimation of insulin sensitivity. Am. J. Physiol., 236, E667-E677.
4. Bergstrom, R.W., Newell-Morris, L.L., Leonetti, D.L.; Shuman, W.P., Wahl, P.W. & Fujimoto, W.Y. (1990) Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes, 39, 104-111.
5. Chan, W.B., Tong, P.C., Chow, C.C., So, W.Y., Ng, M.C., Ma, R.C., Osaki, R., Cockram, C.S. & Chan, J.C. (2004) The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients. Diabet. Med., 21, 349-351.
6. Chen, W., Srinivasan, S.R., Elkasabany, A. & Berenson, G.S. (1999) Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am. J. Epidemiol., 150, 667-674.
7. Crook, M.A., Goldsmith, L., Ameerally, P., Lumb, P., Singh, N., Miell, J. & Russell, J.D. (2002) Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucose. Ann. Clin. Biochem., 39, 606-608.
8. Cureton, E.E. & D'Agostino, R.B. (1983) Factor Analysis: An Applied Approach. Lawrence Erlbaum, Hilside, NJ, USA.
9. Davies, M.J., Raymond, N.T., Day, J.L,, Hales, C.N. & Burden, A.C. (2000) Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet. Med., 17, 433-440.
10. De Fronzo, R.T.J. & Andres, R..,(1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol., 237, E214-E223.
11. Del Prato, S. (1999) Measurement of insulin resistance in vivo. Drugs, 58, Suppl. 1, 3-6.
12. Edwards, K.L., Austin, M.A., Newman, B., Mayer, E., Krauss, R.M. & Selby, J.V. (1994) Multivariate analysis of the insulin resistance syndrome in women. Arterioscler. Thromb., 14, 1940-1945.
13. Festa, A., D'Agostino, R., Jr., Hanley, A.J., Karter, A.J., Saad, M.F. & Haffner, S.M. (2004) Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes, 53, 1549-1555.
14. Gray, R.S., Fabsitz, R.R., Cowan, L.D., Lee, E.T., Howard, B.V. & Savage, P.J. (1998) Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study. Am. J. Epidemiol., 148, 869-878.
15. Greenfield, M.S., Doberne, L., Kraemer, F., Tobey, T. & Reaven, G. (1984) Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes, 30, 387-392.
16. Guerrero-Romero, F. & Rodriguez-Moran, M. (2001) Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose. J. Diabetes Complications, 15, 34-37.
17. Hanefeld, M., Koehler, C., Fuecker, K., Henkel, E., Schaper, F. & Temelkova-Kurktschiev, T. (2003) Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care, 26, 868-874.
18. Hanley, A.J., Karter, A.J, Festa, A., D'Agostino, R., Jr., Wagenknecht, L.E., Savage, P., Tracy, R.P., Saad, M.F. & Haffner, S. (2002) Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes, 51, 2642-2647.
19. Harano, Y., Ohgaku, S., Hidaka, H., Haneda, K., Kikkawa, R., Shigeta, Y. & Abe, H. (1977) Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J. Clin. Endocrinol. Metab., 45, 1124-1127.
20. Heldgaard, P.E., Olivarius Nde, F., Hindsberger, C. & Henriksen, J.E. (2004) Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease. Diabet. Med., 21, 363-370.
21. Hosker, J.P., Matthews, D.R., Rudenski, A.S., Burnett, M.A., Darling, P., Bown, E.G. & Turner, R.C. (1985) Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia, 28, 401-411.
22. Kahn, S.E. (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia, 46, 3-19.
23. Kline, P. (1994) An Easy Guide to Factor Analysis. Routledge, London.
24. Lemieux, S., Prud'homme, D., Bouchard, C., Tremblay, A. & Despress, J.P. (1996) A single threshold value of waist girth identifies normal weight and overweight subjects with excess visceral adipose tissue. Am. J. Clin. Nutr., 64, 685-693.
25. Li, C.L., Tsai, S.T. & Chou, P. (2002) Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment: The Kinmen Study. J. Clin. Epidemiol., 55, 19-24.
26. Looker, H.C., Knowler, W.C. & Hanson, R.L. (2001) Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care, 24, 1917-1922.
27. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
28. Meigs, J.B., D'Agostino, R.B., Wilson, P.W.F., Cupples, L.A., Nathan, D.M. & Singer, D.E. (1997) Risk variable clustering in the insulin resistance syndrome: the Framingham Offspring Study. Diabites, 46, 1594-1600.
29. Meigs, J.B. (2000) Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am. J. Epidemiol., 152, 908-911.
30. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) Executive Summary of Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III). JAMA, 285, 2486-2497.
31. Ostenson, C.G. (2001) The pathophysiology of type 2 diabetes mellitus: an overview. Acta Physiol. Scand., 171, 241-247.
32. Pallardo, L.F., Herranz, L., Martin, V.P., Garcia, I.T., Grande, C. & Janez, M. (2003) Impaired fasting glucose and impaired glucose tolerance in women with prior gestational diabetes are associated with a different cardiovascular profile. Diabetes Care, 26, 2318-2322.
33. Sakkinen, P.A., Wahl, P., Cushman, M., Lewis, M.R. & Tracy, R.P. (2000) Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am. J. Epidemiol., 152, 897-907.
34. Snehalatha, C., Sivasankari, S., Satyavani, K., Vijay, V. & Ramachandran, A. (2000) Insulin resistance alone dose not explain the clustering of cardiovascular risk factors in southern India. Diabet. Med., 17, 152-157.
35. Snehalatha, C., Ramachandran, A., Sivasankari, S., Satyavani, K. & Vijay, V. (2003) Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians. Diabetes Metab. Res. Rev., 19, 329-332.
36. Tripathy, D., Carlsson, M., Almgren, P., Isomaa, B., Taskinen, M.R., Tuomi, T. & Groop, L.C. (2000) Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes, 49, 975-980.
37. Wallace, T.M., Levy, J.C. & Matthews, D.R. (2004) Use and Abuse of HOMA modeling. Diabetes Care, 27, 1487-1495.
38. Watson, R. (1998) Publishing the results of factor analysis: interpretation and presentation. J. Adv. Nurs., 28, 1361-1363.
39. World Health Organization (1985) Diabetes Mellitus: Report of a WHO Study Group. Tech.Rep.Ser., No. 727, World Health Orgpnization, Geneva.